XML 13 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities    
Net loss $ (89,970) $ (96,851)
Adjustments to reconcile net loss to net cash from operating activities    
Depreciation, amortization, and impairment 64,243 44,067
Inventory reserve expenses 27,776 19,347
Amortization of inventory fair value step-up   9,141
Amortization of operating lease assets, debt costs, and other assets 3,959 4,601
Provision for expected credit losses 2,466 2,059
Deferred income taxes 333 1,505
Share-based compensation expense 21,474 25,290
Loss on disposal of fixed assets 861 2,853
Change in valuation of investment securities (41) 7,121
Change in fair value of contingent consideration (1,800) 6,210
Other 1,127 3,288
Changes in operating assets and liabilities    
Accounts receivable 3,131 1,301
Inventories (9,469) (9,820)
Prepaid expenses and other current assets 797 1,410
Accounts payable (5,656) (11,374)
Other current liabilities (9,052) (2,870)
Contingent consideration milestone payment (1,340)  
Other long-term assets and liabilities (3,189) (5,218)
Net cash provided by operating activities 5,650 2,060
Cash flows from investing activities    
Capital expenditures (23,749) (26,345)
Other investing activities 22 (100)
Net cash used in investing activities (23,727) (26,445)
Cash flows from financing activities    
Proceeds from issuance of common shares 3,090 3,311
Payments related to tax withholdings for share-based compensation (168) (4,947)
Payments related to finance lease obligation (564) (525)
Borrowings under credit facility   40,000
Repayment of borrowings from credit facility   (15,000)
Contingent consideration milestone payment (4,990) (1,000)
Payment of debt issuance costs and other financing activities (531) (2,617)
Net cash provided by (used in) financing activities (3,163) 19,222
Effect of exchange rate changes on cash 1,448 (40)
Net change in cash and cash equivalents (19,792) (5,203)
Cash, cash equivalents, and restricted cash at the beginning of period 85,738 37,757
Cash, cash equivalents, and restricted cash at the end of period 65,946 32,554
Components of cash, cash equivalents, and restricted cash at the end of period    
Cash and cash equivalents 62,860 30,054
Restricted cash 3,086 2,500
Cash, cash equivalents, and restricted cash at the end of period 65,946 32,554
Noncash investing activities - Accrued purchases of capital expenditures 12,923 7,261
Noncash investing activities - Purchase of intangible assets $ 40 $ 0